Most US adults are declining COVID boosters as CDC warns of health risks: 'Relatively little...
Fox News· 5 days agoAdults who aren’t current on their COVID-19 vaccine booster doses may have "relatively little...
CDC: Arcturus Responsible for 18% of New COVID-19 Cases
US News & World Report· 37 minutes agoThe so-called arcturus COVID-19 variant is slowly gaining ground across the U.S. Arcturus, or...
China's rolling COVID waves could hit every six months — infecting millions
Nature· 3 days agoThe latest surge in COVID-19 cases in China is not surprising to researchers, who say that China...
The coronavirus has made itself at home in animals. Why that ramps up the risk for people
Los Angeles Times· 9 hours agoThe COVID-19 pandemic is receding fast into our collective memory. The coronavirus that prompted...
How Long Before I Can Travel Safely?
WebMD· 7 days agoIt means that everyone around us—on the plane, in the museum, at the café, and in the communities of every person who enjoys or works in travel—is safe...
These Are The Vaccines You Need If You're Over 50
HuffPost Life via Yahoo News· 4 days agoTrish Perl, a professor in the department of internal medicine who specializes...Thai said. Beyond the recommended vaccines, people who frequently travel...
Next winter could be a calmer RSV season
Salon.com· 4 days agoCOVID-19 hasn't been the only threat to parents and their children since 2020. Concerns about the flu and the respiratory syncytial virus (RSV) have also...
The public health emergency is over — now what?
The Williamsport Sun-Gazette· 7 days agoAs announced in March, the United States ended the COVID-19 public health emergency on May 11th. The World Health Organization declared its public health ...
At CNN, Bill Gates-funded cultural Marxist content is king regardless of CEO
World Tribune· 3 hours agoNow that CNN has parted ways with CEO Chris Licht, can we all stop pretending that the former...
Advances in HIV Vaccine Research Show Promise for Prevention
Medscape· 2 days agoThis article will address the different vaccine platforms and targets; the results of recent clinical trials, such as the Mosaico and Imbokodo studies; the production of broadly neutralizing ...